• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

科学来源:我们能信任谁?

Sources in science: who can we trust?

作者信息

Wilkie T

出版信息

Lancet. 1996 May 11;347(9011):1308-11. doi: 10.1016/s0140-6736(96)90947-2.

DOI:10.1016/s0140-6736(96)90947-2
PMID:8622510
Abstract

Journalists' sources of medical and scientific news seem limitless--journals, press releases, press conferences, newsletters, scientific meetings, and "tipoffs". But whether any one piece of information satisfies two important criteria-journalistic interest and scientific credibility-is another matter. Peer-reviewed journals, in particular, are perceived to be trustworthy sources. Yet, there are increasing concerns in scientific publishing about commercial pressures from pharmaceutical companies, honorary authorship, scientific error, and outright fraud, which journalists cannot be expected to detect. That is down to the scientific community, which must recognise the importance of maintaining impartial sources of public information.

摘要

记者获取医学和科学新闻的来源似乎无穷无尽——期刊、新闻稿、新闻发布会、时事通讯、科学会议以及“爆料”。但某一条信息是否满足两个重要标准——新闻价值和科学可信度——则是另一回事。尤其是经过同行评审的期刊,被视为可靠的信息来源。然而,科学出版界越来越担心制药公司的商业压力、荣誉作者身份、科学错误以及彻头彻尾的欺诈行为,而这些是不能指望记者去发现的。这要靠科学界,科学界必须认识到维护公正的公共信息来源的重要性。

相似文献

1
Sources in science: who can we trust?科学来源:我们能信任谁?
Lancet. 1996 May 11;347(9011):1308-11. doi: 10.1016/s0140-6736(96)90947-2.
2
Exaggerations and Caveats in Press Releases and Health-Related Science News.新闻稿和健康相关科学新闻中的夸张表述与注意事项。
PLoS One. 2016 Dec 15;11(12):e0168217. doi: 10.1371/journal.pone.0168217. eCollection 2016.
3
Press releases of science journal articles and subsequent newspaper stories on the same topic.科学期刊文章的新闻稿以及随后关于同一主题的报纸报道。
JAMA. 1998 Jul 15;280(3):294-5. doi: 10.1001/jama.280.3.294.
4
The spectre of ghostwriting: eroding public trust in physicians, clinical trial integrity and biomedical authorship.代笔的幽灵:侵蚀公众对医生的信任、临床试验的诚信以及生物医学著作权。
Int J Clin Pract. 2016 Jul;70(7):630-3. doi: 10.1111/ijcp.12839.
5
Scientific evidence and mass media: Investigating the journalistic intention to represent scientific uncertainty.科学证据与大众媒体:探究新闻报道呈现科学不确定性的意图。
Public Underst Sci. 2016 Nov;25(8):927-943. doi: 10.1177/0963662515625479. Epub 2016 Jan 22.
6
[News about cancer in the press].[媒体上关于癌症的新闻]
Gac Sanit. 2000 Mar-Apr;14(2):139-45. doi: 10.1016/s0213-9111(00)71447-6.
7
Haunted manuscripts: ghost authorship in the medical literature.闹鬼的手稿:医学文献中的幽灵作者现象
Account Res. 2005 Apr-Jun;12(2):103-14. doi: 10.1080/08989620590957175.
8
Scientific journals and their authors' financial interests: a pilot study.科学期刊及其作者的经济利益:一项试点研究。
Psychother Psychosom. 1998 Jul-Oct;67(4-5):194-201. doi: 10.1159/000012281.
9
Media sources, credibility, and perceptions of science: Learning about how people learn about science.媒体来源、可信度与科学认知:了解人们如何获取科学知识。
Public Underst Sci. 2016 Aug;25(6):674-90. doi: 10.1177/0963662515574986. Epub 2015 Mar 19.
10
Press releases: translating research into news.新闻稿:将研究成果转化为新闻报道。
JAMA. 2002 Jun 5;287(21):2856-8. doi: 10.1001/jama.287.21.2856.

引用本文的文献

1
Frequency distribution of journalistic attention for scientific studies and scientific sources: An input-output analysis.期刊对科学研究和科学资源关注度的分布:投入-产出分析。
PLoS One. 2020 Nov 11;15(11):e0241376. doi: 10.1371/journal.pone.0241376. eCollection 2020.
2
Bevacizumab for advanced breast cancer: hope, hype, and hundreds of headlines.贝伐珠单抗治疗晚期乳腺癌:希望、炒作和上百个头条。
Oncologist. 2013;18(11):1174-9. doi: 10.1634/theoncologist.2013-0160. Epub 2013 Sep 26.
3
Characteristics of medical research news reported on front pages of newspapers.
报纸头版报道的医学研究新闻的特点。
PLoS One. 2009 Jul 1;4(7):e6103. doi: 10.1371/journal.pone.0006103.
4
Deconstructing media coverage of trastuzumab (Herceptin): an analysis of national newspaper coverage.解析媒体对曲妥珠单抗(赫赛汀)的报道:对全国性报纸报道的分析
J R Soc Med. 2008 Mar;101(3):125-32. doi: 10.1258/jrsm.2007.070115.
5
Media reporting of tenofovir trials in Cambodia and Cameroon.柬埔寨和喀麦隆替诺福韦试验的媒体报道。
BMC Int Health Hum Rights. 2005 Aug 24;5:6. doi: 10.1186/1472-698X-5-6.
6
The commercialisation of medical and scientific reporting.医学与科学报告的商业化。
PLoS Med. 2004 Dec;1(3):e38. doi: 10.1371/journal.pmed.0010038.
7
The challenge of effectively communicating risk-benefit information.
Drug Saf. 1997 Oct;17(4):216-27. doi: 10.2165/00002018-199717040-00002.